Skip to main content
×
×
Home

Cerebral Pharmacodynamics of Physostigmine in Alzheimer's Disease Investigated Using Single-Photon Computerised Tomography

  • R. Hunter (a1), D. J. Wyper (a2), J. Patterson (a2), M. T. Hansen (a2) and G. M. Goodwin (a3)...
Abstract

The effects of physostigmine on patterns of rCBF in patients with pre-senile Alzheimer's disease were studied using 99mTc-labelled HMPAO SPECT. Regional CBF increased in the left cortex relative to right, with the most significant effect in left frontal and higher frontal regions. Measures of regional brain function, such as SPECT, are an important complement to psychological test batteries in understanding the effects in brain of putative antidementia drugs. SPECT brain imaging could extend our understanding of the action of psychotropic drugs in other major psychiatric illnesses.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Cerebral Pharmacodynamics of Physostigmine in Alzheimer's Disease Investigated Using Single-Photon Computerised Tomography
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Cerebral Pharmacodynamics of Physostigmine in Alzheimer's Disease Investigated Using Single-Photon Computerised Tomography
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Cerebral Pharmacodynamics of Physostigmine in Alzheimer's Disease Investigated Using Single-Photon Computerised Tomography
      Available formats
      ×
Copyright
Corresponding author
Consultant Psychiatrist, Department of Psychological Medicine, Gartnavel Royal Hospital, Glasgow G12 0XH
References
Hide All
Amaducci L. Sorbi S. Albanese A. et al (1981) Choline acetyltransferase (ChAT) activity differs in right and left human temporal lobes. Neurology, 31, 799805.
Becker J. T. Huff F. J. Nebes R. D. et al (1988) Neuropsychological function of Alzheimer's disease: patterns of impairment and rates of progression. Archives of Neurology, 45, 263268.
Bowen D. M. Allen S. J. Benton J. S. et al (1983) Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease. Journal of Neurochemistry, 41, 266272.
Byrne J. & Arie T. (1989) Tetrahydroaminoacridine (THA) in Alzheimer's disease. British Medical Journal, 298, 845846.
Christie J. E. Shering A. Ferguson J. et al (1981) Physostigmine and arecholine: effects of intravenous infusions in Alzheimer presenile dementia. British Journal of Psychiatry, 138, 4650.
Dam M. & London E. D. (1983) Effects of cholinomimetics on glucose utilization in rat brain optic systems. European Journal of Pharmacology, 87, 137140.
Davies P. (1979) Neurotransmitter-related enzymes in senile dementia of Alzheimer type. Brain Research, 171, 319327.
Davies P. & Maloney A. F. J. (1976) Selective loss of central cholinergic neurones in Alzheimer's disease. Lancet, ii, 1403.
Davies P. & Verth A. H. (1978) Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains. Brain Research, 138, 385392.
Davis K. L. & Mohs R. C. (1982) Enhancement of memory process in Alzheimer's disease with multiple dose intravenous physostigmine. American Journal of Psychiatry, 139, 14211424.
Davis S. M. Acherman R. H. Correra J. A. et al (1983) Cerebral blood flow and cerebral vascular CO2 reactivity in stroke-age normal controls. Neurology, 33, 391399.
Folstein M. F. Folstein S. E. & McHugh P. R. (1975) A practical method for grading the cognitive state of patients for the children. Journal of Psychiatric Research, 12, 189198.
Fox P. T. Raichle M. E. Mintun M. A. et al (1988) Non oxidative glucose consumption during focal physiologic neural activity. Science, 241, 462464.
Frackowiak R. S. J. Pozzilli C. Legg N. J. et al (1981) Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain, 104, 753778.
Friedland R. R. & Meibach R. C. (1981) Effects of acetylcholinesterase inhibitors on 2-deoxy-D-glucose uptake in the rat brain. Society of Neuroscience Abstracts, 7, 494.
Friedland R. P. Budinger T. F. Koss E. et al (1985) Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neuroscience Letters, 53, 235240.
Gustafson L. Edvinsson L. Dahlgren N. et al (1987) Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. Psychopharmacology, 93, 3135.
Haxby J. V. Duara R. Grady C. L. et al (1985) Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism, 5, 193200.
Haxby J. V. Grady C. L. Duara R. et al (1986) Neurocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Archives of Neurology, 43, 882883.
Hoffman W. E. Albrecht R. F. Miletich D. J. et al (1986) Cerebrovascular and cerebral metabolic effects of physostigmine, midazolam, and a benzodiazepine antagonist. Anaesthesia and Analgesia, 65, 639644.
Huff F. J. Becker J. T. Belle S. H. et al (1987) Cognitive deficits and clinical diagnosis of Alzheimer's disease. Neurology, 37, 11191124.
Hunter R. McLuskie R. Wyper D. et al (1989) The pattern of function-related regional cerebral blood flow investigated by single photon emission tomography with 99mTc-HMPAO in patients with presenile Alzheimer's disease and Korsakoff's psychosis. Psychological Medicine, 19, 847855.
McKhann G. Drachman D. Folstein M. et al (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS–ADRDA work group. Neurology, 34, 939944.
Moossy J. Hanin I. Martinez A. J. et al (1985) Lateral variations in morphological and cholinergic markers in Alzheimer's disease and other dementias. Journal of Neuropathology and Experimental Neurology, 44, 329.
Moossy J. Zubenko G. S. Martinez A. J. et al (1989) Lateralization of brain morphologic and cholinergic abnormalities in Alzheimer's disease. Archives of Neurology, 46, 639642.
Neirinckx R. D. Canning L. R. Piper I. M. et al (1987) Technetium-99m d,1–HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. Journal of Nuclear Medicine, 28, 191202.
Nelson S. T. Doull J. Tockman B. A. et al (1978) Regional brain metabolism changes induced by acetylcholinesterase inhibitors. Brain Research, 157, 186192.
Oldfield R. (1971) The assessment and analysis of h andedness: the Edinburgh inventory. Neuropsychologia, 9, 97113.
Palacios J. M. (1982) Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia. Brain Research, 243, 173175.
Perry E. K. (1986) The cholinergic hypothesis – ten years on. British Medical Bulletin, 42, 6369.
Richter J. A. Perry E. K. & Tomlinson B. E. (1980) Acetylcholine and choline levels in post mortem brain tissue: preliminary observations in Alzheimer's disease. Life Science, 26, 16831689.
Rossor M. N. Garrett N. J. Johnson A. L. et al (1982) A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain, 105, 313330.
Rossor M. N. Iversen L. L. Reynolds G. P. et al (1984) Neurochemical characteristics of early and late onset types of Alzheimer disease. British Medical Journal, 288, 961964.
Roth M. Tym E. Mountjoy F. et al (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. British Journal of Psychiatry, 149, 698709.
Saletu B. Darragh A. Salmon P. et al (1989) EEG brain mapping in evaluating the time-course of the central action of DUP 9% – a new acetylcholine releasing drug. British Journal of Clinical Pharmacology, 28, 116.
Scremin O. U. Rovere A. A. & Raynald A. C. (1973) Cholinergic control of blood flow in the cerebral cortex of the rat. Stroke, 4, 232239.
Sims N. R. Bowen D. M. Allen S. J. et al (1983) Presynaptic cholinergic dysfunctions in patients with dementia. Journal of Neurochemistry, 40, 503509.
Sokoloff L. (1959) The action of drugs on the cerebral circulation. Pharmacological Reviews, 11, 185.
Sokoloff L. (1981) Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. Journal of Cerebral Blood Flow and Metabolism, 1, 736.
Stern Y. Sano M. & Mayeux R. (1987) Effects of oral physostigmine in Alzheimer's disease. Annals of Neurology, 22, 306310.
Summers W. K. Majorski L. V. Marsh G. M. et al (1986) Oral tetrahydroaminoacridine in long-term treatment of senile dementia. New England Journal of Medicine, 315, 12411245.
Tomlinson B. E. & Corsellis J. A. N. (1984) Ageing and the dementias. In Greenfield's Neuropathology (eds Hume Adams J. Corsellis J. A. N. & Duchen L. W.), pp. 9511025. London: Edward Arnold.
Weinberger D. R. Gibson R. E. Coppola R. et al (1989) Distribution of muscarinic receptors in patients with dementia: a controlled study of 123I-QNB and SPECT. Journal of Cerebral Blood Flow and Metabolism, 9 (suppl. 1), S537.
Wesnes K. Simmons D. Rook M. et al (1987) A double-blind placebo controlled trial of Tanakan in the treatment of idiopathic cognitive impairment in the elderly. Human Psychopharmacology, 2, 159169.
Whalley L. J. (1989) Drug treatments of dementia. British Journal of Psychiatry, 155, 595611.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 1 *
Loading metrics...

Abstract views

Total abstract views: 3 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 23rd January 2018. This data will be updated every 24 hours.